CHEBI:76252 - mofebutazone

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name mofebutazone
ChEBI ID CHEBI:76252
Definition A pyrazolidine that is phenylbutazone lacking one of the phenyl substituents. It is used for treatment of joint and muscular pain.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C13H16N2O2
Net Charge 0
Average Mass 232.27830
Monoisotopic Mass 232.12118
InChI InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16)
InChIKey REOJLIXKJWXUGB-UHFFFAOYSA-N
SMILES CCCCC1C(=O)NN(C1=O)c1ccccc1
Roles Classification
Biological Role(s): non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
Application(s): non-steroidal anti-inflammatory drug
An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing mofebutazone (CHEBI:76252) has role non-narcotic analgesic (CHEBI:35481)
mofebutazone (CHEBI:76252) has role non-steroidal anti-inflammatory drug (CHEBI:35475)
mofebutazone (CHEBI:76252) is a pyrazolidines (CHEBI:38312)
IUPAC Name
4-butyl-1-phenylpyrazolidine-3,5-dione
INNs Sources
mofebutazona ChemIDplus
mofébutazone WHO MedNet
mofebutazone KEGG DRUG
mofebutazonum ChemIDplus
nabumétone WHO MedNet
Synonyms Sources
1-Phenyl-4-butyl-3,5-pyrazolidinedione NIST Chemistry WebBook
2 Fdbp ChemIDplus
2-Phenyl-3,5-dihydroxy-4-butylpyrazolidine ChemIDplus
4-Butyl-1-phenyl-3,5-dioxopyrazolidine ChemIDplus
4-Butyl-1-phenyl-3,5-pyrazolidinedione ChemIDplus
Monophenylbutazone ChemIDplus
Mophebutazone ChemIDplus
Brand Name Source
Monazone KEGG DRUG
Manual Xrefs Databases
1828 DrugCentral
Mofebutazone Wikipedia
View more database links
Registry Numbers Types Sources
213056 Reaxys Registry Number Reaxys
2210-63-1 CAS Registry Number NIST Chemistry WebBook
2210-63-1 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
1492846 PubMed citation Europe PMC
1547984 PubMed citation Europe PMC
1865336 PubMed citation Europe PMC
3092599 PubMed citation Europe PMC
3092600 PubMed citation Europe PMC
3440938 PubMed citation Europe PMC
3481307 PubMed citation Europe PMC
3727816 PubMed citation Europe PMC
3805210 PubMed citation Europe PMC
4050150 PubMed citation Europe PMC
6495891 PubMed citation Europe PMC
6519123 PubMed citation Europe PMC
7250143 PubMed citation Europe PMC
7250148 PubMed citation Europe PMC
8024638 PubMed citation Europe PMC
8200720 PubMed citation Europe PMC
8406274 PubMed citation Europe PMC
8871264 PubMed citation Europe PMC
9034692 PubMed citation Europe PMC
Last Modified
22 February 2017